[Interaction between gabapentin and D-serin in the formalin orofacial test]

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Gabapentin is recognized for treating trigeminal neuralgia and orofacial phantom pain.
• Limited data exists on gabapentin's analgesic efficacy in orofacial pain models.

Purpose of the Study:

• To investigate the analgesic action of gabapentin in a rat orofacial pain model.
• To explore the interaction between gabapentin and D-serine in orofacial pain.

Main Methods:

• Utilized the formalin-induced face grooming test in rats as an orofacial pain paradigm.
• Administered intraperitoneal (IP) gabapentin at 10 mg/kg and 1 mg/kg.
• Administered intracerebroventricular (ICV) D-serine (100 microg) alone and in combination with gabapentin.

Main Results:

• Gabapentin (10 mg/kg) significantly reduced face grooming in both phase I and II, indicating antinociception.
• Gabapentin (1 mg/kg) showed analgesia only in phase I.
• D-serine alone had no effect, but gabapentin (1 mg/kg) combined with D-serine reduced face grooming in phase II.

Conclusions:

• Gabapentin exhibits a dose-dependent analgesic effect in the formalin-induced orofacial pain model.
• The interaction between gabapentin and D-serine suggests distinct pain processing pathways for orofacial versus hind paw stimulation.
• Further research is needed to elucidate the mechanisms underlying gabapentin's orofacial analgesia and D-serine modulation.